SEC Form 4 · accession 0000891293-15-000024

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Corporate Development

Period of report

Jul 6, 2015

Accepted (ET)

Jul 8, 2015 · 5:54 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jul 6, 2015	S	1,300	$1.92	D	690,440	D
Common Stock	Jul 6, 2015	S	700	$1.925	D	689,740	D
Common Stock	Jul 6, 2015	S	100	$1.928	D	689,640	D
Common Stock	Jul 6, 2015	S	1,700	$1.93	D	687,940	D
Common Stock	Jul 6, 2015	S	1,200	$1.945	D	686,740	D
Common Stock	Jul 6, 2015	S	400	$1.95	D	686,340	D
Common Stock	Jul 6, 2015	S	1,000	$1.96	D	685,340	D
Common Stock	Jul 6, 2015	S	700	$1.965	D	684,640	D
Common Stock	Jul 6, 2015	S	444	$1.97	D	684,196	D
Common Stock	Jul 6, 2015	S	2,256	$1.975	D	681,940	D
Common Stock	Jul 6, 2015	S	200	$1.98	D	681,740	D

No Table II lines on this filing.